Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases. |
Synonyms | Tofacitinib metabolite M2, CP-690,550A, UNII-Q7ZOK859UK |
Molecular Weight | 303.36 |
Formula | C15H21N5O2 |
CAS No. | 1243290-37-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CP-690550A 1243290-37-0 CP690550A Tofacitinib metabolite M2 CP 690550A CP-690,550A UNII-Q7ZOK859UK inhibitor inhibit